RhoVac AB (now known as Chosa Oncology AB) has completed the acquisition of Chosa ApS

RhoVac AB has completed the acquisition of the Danish privately owned oncology company Chosa ApS (“Chosa”). As a result, a new board of directors of Chosa has taken office, and Peter Buhl Jensen replaces Lars Hedbys as CEO. More details on the Chosa website.